Page last updated: 2024-11-02

pioglitazone and Hypothyroidism

pioglitazone has been researched along with Hypothyroidism in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research Excerpts

ExcerptRelevanceReference
"Hypothyroidism was induced by PTU administration, which was indicated by lower serum thyroxine levels."4.12Cardiovascular protective effects of PPARĪ³ agonists in hypothyroid rats: protection against oxidative stress. ( Ali-Hassanzadeh, M; Baghcheghi, Y; Beheshti, F; Gowhari-Shabgah, A; Hedayati-Moghadam, M; Hosseini, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Baghcheghi, Y1
Beheshti, F1
Hosseini, M1
Gowhari-Shabgah, A1
Ali-Hassanzadeh, M1
Hedayati-Moghadam, M1
Alhowail, AH1

Other Studies

2 other studies available for pioglitazone and Hypothyroidism

ArticleYear
Cardiovascular protective effects of PPARĪ³ agonists in hypothyroid rats: protection against oxidative stress.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2022, Aug-18, Volume: 44, Issue:6

    Topics: Animals; Antioxidants; Heart; Hypothyroidism; Oxidative Stress; Pioglitazone; PPAR gamma; Propylthio

2022
Pioglitazone ameliorates doxorubicin-induced hypothyroidism and cardiotoxicity in rat models.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:19

    Topics: Animals; Cardiotoxicity; Creatine Kinase; Creatine Kinase, MB Form; Doxorubicin; Female; Hypothyroid

2023